Recursion Pharmaceuticals, Inc.
RXRX
$4.94
$0.163.35%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 525.11M | 500.45M | 594.35M | 427.65M | 474.34M |
| Total Receivables | 21.61M | 46.12M | 49.17M | 2.26M | 2.53M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 2.47M | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 40.44M | 35.10M | 70.75M | 44.27M | 45.51M |
| Total Current Assets | 587.16M | 584.15M | 714.27M | 474.17M | 522.38M |
|
|
|||||
| Total Current Assets | 587.16M | 584.15M | 714.27M | 474.17M | 522.38M |
| Net Property, Plant & Equipment | 193.60M | 204.78M | 233.21M | 159.19M | 156.28M |
| Long-term Investments | 164.27M | 158.11M | 148.87M | 52.06M | 52.06M |
| Goodwill | 164.27M | 158.11M | 148.87M | 52.06M | 52.06M |
| Total Other Intangibles | 341.32M | 335.79M | 335.86M | 34.09M | 38.21M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.60M | 18.01M | 16.39M | 6.99M | 6.94M |
| Total Assets | 1.30B | 1.31B | 1.45B | 726.50M | 775.86M |
|
|
|||||
| Total Accounts Payable | 19.31M | 25.09M | 21.61M | 2.26M | 3.76M |
| Total Accrued Expenses | 83.00M | 55.18M | 80.28M | 38.71M | 31.48M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 20.48M | 20.44M | 22.22M | 16.45M | 16.72M |
| Total Finance Division Other Current Liabilities | 41.23M | 41.28M | 63.36M | 51.47M | 34.12M |
| Total Other Current Liabilities | 41.23M | 41.28M | 63.36M | 51.47M | 34.12M |
| Total Current Liabilities | 164.03M | 141.98M | 187.47M | 108.89M | 86.08M |
|
|
|||||
| Total Current Liabilities | 164.03M | 141.98M | 187.47M | 108.89M | 86.08M |
| Long-Term Debt | 14.20M | 16.45M | 684.00K | 1.02M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 53.40M | 56.02M | 85.59M | 73.16M | 73.16M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 151.59M | 156.84M | 140.07M | 18.88M | 32.17M |
| Total Liabilities | 383.21M | 371.29M | 413.82M | 201.94M | 191.41M |
|
|
|||||
| Common Stock & APIC | 2.68B | 2.55B | 2.47B | 1.78B | 1.74B |
| Retained Earnings | -1.81B | -1.63B | -1.43B | -1.25B | -1.16B |
| Treasury Stock & Other | 43.62M | 14.15M | -7.64M | -- | -- |
| Total Common Equity | 919.15M | 933.95M | 1.03B | 524.56M | 584.45M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 919.15M | 933.95M | 1.03B | 524.56M | 584.45M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 919.15M | 933.95M | 1.03B | 524.56M | 584.45M |
|
|
|||||